Intended Use:

The AESKULISA^® SARS-CoV-2 IgA, IgG and IgM tests are qualitative and quantitative immuno-assays for the demonstration of human IgA, IgG or IgM antibodies in serum or plasma directed against the nucleocapsid protein of SARS-CoV-2. The AESKULISA^® SARS-CoV-2 NP IgM and IgA tests assist in the detection of acute infections. The AESKULISA^® SARS-CoV-2 NP IgG test serves for confirmation of a contact with the pathogen and supports in immune status determination.

Recombinant Antigens:

Recombinant Nucleocapsid Protein from SARS-CoV-2

Native Antigens:

n.a.